
Loading, please wait...

Loading, please wait...

Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of heart attacks in young women. Clinicians often observe a significant link between SCAD and oral contraceptives, particularly in patients without traditional risk factors. A recent case report highlights a 32-year-old woman who experienced an acute myocardial infarction (AMI) while taking combined hormonal birth control for four months.
While the exact mechanism remains unclear, hormonal factors significantly influence arterial wall integrity. Consequently, the high estrogen states associated with SCAD and oral contraceptives may predispose individuals to intimal tears or intramural hematomas. In this specific case, the patient presented with acute chest pain and ST-segment elevation. Coronary angiography initially showed diffuse narrowing of the left anterior descending (LAD) artery. However, the condition improved after intracoronary nitroglycerin administration. Subsequent optical coherence tomography (OCT) confirmed an intramural hematoma, which is a hallmark of SCAD.
Early identification is crucial for achieving favorable outcomes in young female patients presenting with acute coronary syndrome. Therefore, physicians must maintain a high clinical suspicion of SCAD when traditional atherosclerotic risks are absent. In this case, the medical team opted for conservative management rather than invasive stenting. Follow-up imaging at six weeks showed significant healing of the vessel. Furthermore, the patient recovered fully with normalized left ventricular function at the one-year mark. This outcome supports the current preference for non-invasive strategies in stable SCAD patients.
Exogenous hormones can alter the proteoglycan composition and collagen synthesis within the arterial media. These changes potentially weaken the vessel wall, making it susceptible to spontaneous dissection under stress.
While coronary angiography is the first step, advanced intravascular imaging like Optical Coherence Tomography (OCT) or Intravascular Ultrasound (IVUS) provides definitive evidence of intramural hematomas or false lumens.
Typically, clinicians recommend discontinuing systemic hormonal contraceptives after a SCAD event. Patients should instead consider non-hormonal alternatives or progestin-only intrauterine devices to minimize recurrence risks.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A case report detailing a 32-year-old woman's AMI caused by SCAD linked to oral contraceptive use, emphasizing diagnostic suspicion and conservative managem...
8 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday